Crossroads Treatment Center West Philadelphia

Crossroads Treatment Center West Philadelphia is an addiction-treatment facility located in Tacoma, WA. The facility's programming is outpatient (IOP), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Crossroads Treatment Center West Philadelphia

On care levels specifically: Crossroads Treatment Center West Philadelphia is an outpatient-focused program (IOP) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Crossroads Treatment Center West Philadelphia to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Crossroads Treatment Center West Philadelphia accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adolescents. Specialty programming varies substantially by facility — some facilities offer "dual diagnosis" as a marketing category but not a clinical differentiator. Ask for the specific clinical-team credentials and the actual hours of specialty-specific content per week.

Before you call

Three questions to put to Crossroads Treatment Center West Philadelphia before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). If the clinical situation involves opioid use disorder, confirm explicitly whether Crossroads Treatment Center West Philadelphia offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Getting answers in writing protects against the downstream surprises.